Melanie Moyo

Blantyre, S, Malawi

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Antiretroviral Therapy Management in Cryptococcal Meningitis.

Antiretroviral Therapy Management in Cryptococcal Meningitis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 14, 2025

Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.

Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.

Journal: Open forum infectious diseases

Published: February 25, 2025

Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis.

Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis.

Journal: mBio

Published: August 27, 2024

Household economic impact of HIV-associated cryptococcal meningitis in five countries in Southern and Eastern Africa.

Household economic impact of HIV-associated cryptococcal meningitis in five countries in Southern and Eastern Africa.

Journal: Journal of the International AIDS Society

Published: August 01, 2024

Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa.

Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 17, 2024

Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study.

Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study.

Journal: The Lancet. Microbe

Published: January 26, 2023

Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis.

Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis.

Journal: The Journal of antimicrobial chemotherapy

Published: November 25, 2022

Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis.

Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis.

Journal: The Journal of antimicrobial chemotherapy

Published: August 22, 2022

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial.

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial.

Journal: The Lancet. Global health

Published: April 30, 2022

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.

Journal: The New England journal of medicine

Published: March 23, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026